You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
5 December 2023
Merck KGaA: Phase III trial results for evobrutinib in relapsing multiple sclerosis did not meet primary endpoint of reducing annualized relapse rates (ARR) compared to oral teriflunomide
3 November 2021
Merck KGaA raises forecast for full year 2021
4 May 2021
20 January 2021
Merck KGaA: Merck KGaA to discontinue bintrafusp alfa clinical trial (INTR@PID Lung 037)
29 September 2020
Merck KGaA: Merck KGaA reverses provision for lawsuit in the amount of EUR 365 million
27 February 2019
Merck KGaA: Merck Proposes to Acquire Versum for USD 48 per Share and to Create a Leading Electronic Materials Player